These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 11212355)

  • 1. Oxazolidinones: a novel class of antibiotics.
    Müller M; Schimz KL
    Cell Mol Life Sci; 1999 Oct; 56(3-4):280-5. PubMed ID: 11212355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On the target of a novel class of antibiotics, oxazolidinones, active against multidrug-resistant Gram-positive bacteria.
    Burghardt H; Schimz KL; Müller M
    FEBS Lett; 1998 Mar; 425(1):40-4. PubMed ID: 9541003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The oxazolidinones as a new family of antimicrobial agent.
    Marchese A; Schito GC
    Clin Microbiol Infect; 2001; 7 Suppl 4():66-74. PubMed ID: 11688536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tedizolid: a new oxazolidinone antimicrobial.
    Kisgen JJ; Mansour H; Unger NR; Childs LM
    Am J Health Syst Pharm; 2014 Apr; 71(8):621-33. PubMed ID: 24688035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxazolidinone antimicrobials: a patent review (2012-2015).
    Phillips OA; Sharaf LH
    Expert Opin Ther Pat; 2016 May; 26(5):591-605. PubMed ID: 26998627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tedizolid: a novel oxazolidinone for Gram-positive infections.
    Moellering RC
    Clin Infect Dis; 2014 Jan; 58 Suppl 1():S1-3. PubMed ID: 24343826
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of gram-positive surgical sepsis: role of the oxazolidinones.
    Colizza S; Rossi S; Rodio F; Carnuccio P; Cucchiara G
    J Chemother; 2003 Aug; 15(4):323-8. PubMed ID: 12962359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxazolidinone antibiotics.
    Diekema DJ; Jones RN
    Lancet; 2001 Dec; 358(9297):1975-82. PubMed ID: 11747939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tedizolid: a novel oxazolidinone with potent activity against multidrug-resistant gram-positive pathogens.
    Zhanel GG; Love R; Adam H; Golden A; Zelenitsky S; Schweizer F; Gorityala B; Lagacé-Wiens PR; Rubinstein E; Walkty A; Gin AS; Gilmour M; Hoban DJ; Lynch JP; Karlowsky JA
    Drugs; 2015 Feb; 75(3):253-70. PubMed ID: 25673021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Linezolid in vitro: mechanism and antibacterial spectrum.
    Livermore DM
    J Antimicrob Chemother; 2003 May; 51 Suppl 2():ii9-16. PubMed ID: 12730138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AZD-2563 AstraZeneca.
    Johnson AP
    Curr Opin Investig Drugs; 2002 Jun; 3(6):848-52. PubMed ID: 12137402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Linezolid for the treatment of resistant gram-positive cocci.
    Bain KT; Wittbrodt ET
    Ann Pharmacother; 2001 May; 35(5):566-75. PubMed ID: 11346064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment options for vancomycin-resistant enterococcal infections.
    Linden PK
    Drugs; 2002; 62(3):425-41. PubMed ID: 11827558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Pharmacokinetics and Pharmacodynamics of Oxazolidinones.
    Roger C; Roberts JA; Muller L
    Clin Pharmacokinet; 2018 May; 57(5):559-575. PubMed ID: 29063519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Linezolid.
    French G
    Int J Clin Pract; 2001; 55(1):59-63. PubMed ID: 11219321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxazolidinones: activity, mode of action, and mechanism of resistance.
    Bozdogan B; Appelbaum PC
    Int J Antimicrob Agents; 2004 Feb; 23(2):113-9. PubMed ID: 15013035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Linezolid--a review of the first oxazolidinone.
    Norrby R
    Expert Opin Pharmacother; 2001 Feb; 2(2):293-302. PubMed ID: 11336587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Linezolid--new antibacterial agent of the oxazolidinone group: its importance in the control of spreading and treatment of the multidrug resistance gram-positive infections].
    Budanov SV; Smirnova LB
    Antibiot Khimioter; 2002; 47(7):38-42. PubMed ID: 12516195
    [No Abstract]   [Full Text] [Related]  

  • 19. Synthesis and antibacterial activity of novel oxazolidinones bearing N-hydroxyacetamidine substituent.
    Takhi M; Murugan C; Munikumar M; Bhaskarreddy KM; Singh G; Sreenivas K; Sitaramkumar M; Selvakumar N; Das J; Trehan S; Iqbal J
    Bioorg Med Chem Lett; 2006 May; 16(9):2391-5. PubMed ID: 16488606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conformational constraint in oxazolidinone antibacterials. Part 2: Synthesis and structure-activity studies of oxa-, aza-, and thiabicyclo[3.1.0]hexylphenyl oxazolidinones.
    Renslo AR; Gao H; Jaishankar P; Venkatachalam R; Gómez M; Blais J; Huband M; Vara Prasad JV; Gordeev MF
    Bioorg Med Chem Lett; 2006 Mar; 16(5):1126-9. PubMed ID: 16387498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.